Trump Launches TrumpRx.gov — A New Discount Site for Prescription Drugs (Feb 2026)
What happened?
On February 5, 2026, President Donald Trump announced and unveiled TrumpRx.gov, a government-backed website aimed at helping Americans access lower-priced prescription drugs. The site is part of a broader push to reduce drug costs using “most-favored-nation” (MFN) pricing — meaning U.S. patients pay no more than the lowest prices paid in other developed countries.
How does TrumpRx actually work?
- It is not an online pharmacy where you buy drugs directly from the site.
- Instead, it acts as a central hub / landing page.
- You search for your medication → the site shows the discounted price → it provides either:
- printable/downloadable coupons to take to a regular pharmacy, or
- links to the drug company’s own direct-to-consumer purchase platform or mail-order service.
- You still need a valid prescription from your doctor.
- It is designed mainly for people paying cash/out-of-pocket (not using insurance).
Launch details (as of Feb 5–6, 2026)
- Started with ~40–43 branded medications from the first five companies that signed deals:
Pfizer, Eli Lilly, Novo Nordisk, AstraZeneca, EMD Serono - More drugs from the other ~11–12 companies (Merck, GSK, Sanofi, Novartis, Bristol Myers Squibb, Gilead, etc.) are expected to be added in the coming months.
- Pfizer has the largest initial selection (30+ medicines).
- High-profile examples include weight-loss/diabetes drugs:
- Wegovy — listed examples show ~$149–$349/mo (vs list price ~$1,349)
- Ozempic and similar drugs also featured with large discounts
Savings claims
- Discounts are described as “dramatic” / “massive.”
- Pfizer has stated average ~50% off list price (with some drugs up to 85% off).
- The White House and Trump call it “the most impactful prescription price reset in history” and part of making America “healthy again.”
- The deals stem from agreements where pharma companies offered lower prices to Medicaid and direct consumers in exchange for the administration not imposing certain planned pharmaceutical tariffs or other measures.
Background & context
The initiative follows an executive order signed in March 2025 introducing the MFN policy.
Trump announced the first deal (with Pfizer) in late September 2025, followed by more deals throughout late 2025 (including major weight-loss drug makers in November).
Who benefits most?
- Uninsured people
- People whose insurance plan has very high co-pays or doesn’t cover the drug well
- Those choosing to pay cash to get a lower net price than their insurance would provide
Limitations noted in coverage
- Most Americans with good insurance will likely still get lower/fair prices through their plan (so TrumpRx may not change much for them).
- It’s not universal — only drugs from participating companies are included.
- No direct purchasing on the government site itself (you still go through pharmacies or company channels).
Bottom line
TrumpRx.gov is a visible, centralized way to find and access manufacturer discounts that were negotiated as part of 2025 deals between the Trump administration and most major pharmaceutical companies. It’s being presented as a big step toward lowering U.S. drug prices — especially for cash-paying patients — but it builds on existing company discount programs rather than creating an entirely new purchasing system.
Official site: trumprx.gov (launched Feb 5, 2026)
